Insights

Innovative Technology Platform Nostos Genomics offers a CE-certified platform that combines machine learning and synthetic biology to automate mutation interpretation, enabling genetic labs to deliver faster and more accurate diagnoses. This cutting-edge approach presents opportunities to collaborate with labs seeking to upgrade their diagnostic workflows and reduce interpretation labor costs.

Sustainable Market Focus With over 300 million people worldwide affected by rare genetic diseases and current diagnosis delays often exceeding five years, there is a significant market demand for advanced genetic testing solutions. Partnering with labs and healthcare providers involved in rare disease diagnosis can tap into this underserved segment.

Recent Acquisition Boost The recent acquisition by Limbus Medtec indicates strong industry validation and potential for expanded market reach. Business development can leverage this strategic move to explore integration opportunities and co-marketing initiatives within the medical technology sector.

Funding and Growth Potential Having secured approximately 5.7 million dollars in seed funding and maintaining a revenue range of 1 to 10 million dollars, Nostos Genomics demonstrates promising growth potential. Sales efforts can target biotechnology companies and research institutions looking for innovative diagnostic tools to enhance their genetic analysis capabilities.

Partnership and Integration Opportunities Nostos Genomics partners with notable companies like Genomenon, expanding integration options into existing genomic data platforms. This creates opportunities to cross-sell or bundle solutions with data management providers and amplify customer value in genomic research and diagnostics.

Nostos Genomics Tech Stack

Nostos Genomics uses 8 technology products and services including NumPy, Kubernetes, cdnjs, and more. Explore Nostos Genomics's tech stack below.

  • NumPy
    Advanced Analytics And Data Science
  • Kubernetes
    Containerization
  • cdnjs
    Content Delivery Network
  • Cloudflare
    Content Management System
  • CookieScript
    Cookie Compliance
  • HubSpot
    Marketing Automation
  • Microsoft
    Miscellaneous
  • Cloudflare Bot Management
    Security

Nostos Genomics's Email Address Formats

Nostos Genomics uses at least 1 format(s):
Nostos Genomics Email FormatsExamplePercentage
First.Last@nostos-genomics.comJohn.Doe@nostos-genomics.com
46%
First.Middle@nostos-genomics.comJohn.Michael@nostos-genomics.com
4%
First.Last@nostos-genomics.comJohn.Doe@nostos-genomics.com
46%
First.Middle@nostos-genomics.comJohn.Michael@nostos-genomics.com
4%

Frequently Asked Questions

Where is Nostos Genomics's headquarters located?

Minus sign iconPlus sign icon
Nostos Genomics's main headquarters is located at Berlin Kreuzberg, Berlin 10963 Germany. The company has employees across 1 continents, including Europe.

What is Nostos Genomics's official website and social media links?

Minus sign iconPlus sign icon
Nostos Genomics's official website is nostos-genomics.com and has social profiles on LinkedInCrunchbase.

What is Nostos Genomics's NAICS code?

Minus sign iconPlus sign icon
Nostos Genomics's NAICS code is 5112 - Software Publishers.

How many employees does Nostos Genomics have currently?

Minus sign iconPlus sign icon
As of February 2026, Nostos Genomics has approximately 16 employees across 1 continents, including Europe. Key team members include Vp Of Engineering: M. E.Head Of Regulatory Affairs & Prrc: D. S.Co-Founder & Chief Technology Officer: R. A. H.. Explore Nostos Genomics's employee directory with LeadIQ.

What industry does Nostos Genomics belong to?

Minus sign iconPlus sign icon
Nostos Genomics operates in the Software Development industry.

What technology does Nostos Genomics use?

Minus sign iconPlus sign icon
Nostos Genomics's tech stack includes NumPyKubernetescdnjsCloudflareCookieScriptHubSpotMicrosoftCloudflare Bot Management.

What is Nostos Genomics's email format?

Minus sign iconPlus sign icon
Nostos Genomics's email format typically follows the pattern of First.Last@nostos-genomics.com. Find more Nostos Genomics email formats with LeadIQ.

How much funding has Nostos Genomics raised to date?

Minus sign iconPlus sign icon
As of February 2026, Nostos Genomics has raised $5.7M in funding. The last funding round occurred on Jan 31, 2022 for $5.7M.

Nostos Genomics

Software DevelopmentBerlin, Germany11-50 Employees

At Nostos Genomics, we partner with genetic testing labs to turn data into genomic insights and give more people with genetic diseases a fast and clear diagnosis.

Over 300 million people live with a rare genetic disease and for most, the journey from the first symptoms to a diagnosis takes more than 5 years. Even after that, diagnoses are often incorrect, and many people end up not being diagnosed at all.

Now, new technology is allowing millions to benefit from genetic testing for diagnosis, while at the same time targeted therapies for previously untreatable disorders are being developed.

But the last step in genetic testing – interpreting mutations – remains laborious and costly. It can take a genetic testing lab weeks to interpret data from a single patient. Because of limited understanding of the consequences of mutations, the test results are often inconclusive and leave 70% of people undergoing a genetic test without diagnosis.

Our CE-certified platform leverages a unique combination of machine learning and synthetic biology to characterize mutations at scale and automate the interpretation. By offering it to labs, we enable them to diagnose more people in a fraction of the time.

Section iconCompany Overview

Headquarters
Berlin Kreuzberg, Berlin 10963 Germany
NAICS Code
5112 - Software Publishers
Employees
11-50

Section iconFunding & Financials

  • $5.7M

    Nostos Genomics has raised a total of $5.7M of funding over 1 rounds. Their latest funding round was raised on Jan 31, 2022 in the amount of $5.7Mas a seed.

  • $1M$10M

    Nostos Genomics's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $5.7M

    Nostos Genomics has raised a total of $5.7M of funding over 1 rounds. Their latest funding round was raised on Jan 31, 2022 in the amount of $5.7Mas a seed.

  • $1M$10M

    Nostos Genomics's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.